Eli Lilly and Company Sustainability Profile
Eli Lilly and Company, commonly referred to as Lilly, is a global leader in the pharmaceutical industry, headquartered in the United Kingdom. Founded in 1876, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative solutions in diabetes, oncology, immunology, and neuroscience. Lilly is renowned for its pioneering products, such as insulin therapies and cancer treatments, which are distinguished by their commitment to research and development. The company has achieved significant milestones, including the introduction of groundbreaking medications that have transformed patient care. With a robust market position, Eli Lilly continues to be recognised for its contributions to healthcare, consistently ranking among the top pharmaceutical companies worldwide.
DitchCarbon Score
How does Eli Lilly and Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eli Lilly and Company's score of 76 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eli Lilly and Company's reported carbon emissions
In 2024, Eli Lilly and Company reported total greenhouse gas emissions of approximately 192,000,000 kg CO2e for Scope 1 and about 258,000,000 kg CO2e for Scope 2, resulting in combined Scope 1 and 2 emissions of around 450,000,000 kg CO2e. This data reflects a commitment to transparency in emissions reporting, with a focus on reducing their carbon footprint. From 2020 to 2023, Eli Lilly achieved a significant reduction of 26% in absolute emissions across its operations, despite business growth. This reduction encompasses both Scope 1 and Scope 2 emissions, demonstrating the company's proactive approach to sustainability. Notably, they have set a target to achieve carbon neutrality in their own operations (Scope 1 and 2) by 2030, which aligns with their broader climate commitments. Eli Lilly's emissions data is not cascaded from any parent organization, indicating that the figures are independently reported. The company has also disclosed its emissions intensity, with a market-based emissions factor of approximately 0.01 kg CO2e per USD of revenue for 2024. Overall, Eli Lilly and Company is actively working towards enhancing its sustainability practices and reducing its environmental impact, with clear targets and achievements in emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 502,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,310,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 200,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
How Carbon Intensive is Eli Lilly and Company's Industry?
How Carbon Intensive is Eli Lilly and Company's Location?
Eli Lilly and Company's Scope 3 Categories Breakdown
Eli Lilly and Company's Scope 3 emissions, which increased by 62% last year and increased significantly since 2007, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 60% of Scope 3 emissions.
Top Scope 3 Categories
Eli Lilly and Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eli Lilly and Company has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
